日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A Phase-I pharmacokinetic, safety and food-effect study on flubentylosin, a novel analog of Tylosin-A having potent anti-Wolbachia and antifilarial activity

一项关于氟苯泰洛辛（一种具有强效抗沃尔巴克氏体和抗丝虫活性的新型泰洛辛A类似物）的I期药代动力学、安全性和食物影响研究

期刊:PLoS Neglected Tropical Diseases
影响因子:3.4
doi:10.1371/journal.pntd.0011392
Alami, Negar; Carter, David C; Kwatra, Nisha V; Zhao, Weihan; Snodgrass, Linda; Porcalla, Ariel R; Klein, Cheri E; Cohen, Daniel E; Gallenberg, Loretta; Neenan, Melina; Carr, Robert A; Marsh, Kennan C; Kempf, Dale J
发表日期：2023
文献求助 收藏

Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA Study

格卡瑞韦/哌仑他韦在慢性丙型肝炎病毒感染青少年中的药代动力学、安全性和有效性：DORA 研究的第一部分

期刊:Hepatology
影响因子:15.8
doi:10.1002/hep.30840
Jonas, Maureen M; Squires, Robert H; Rhee, Susan M; Lin, Chih-Wei; Bessho, Kazuhiko; Feiterna-Sperling, Cornelia; Hierro, Loreto; Kelly, Deirdre; Ling, Simon C; Strokova, Tatiana; Del Valle-Segarra, Antonio; Lovell, Sandra; Liu, Wei; Ng, Teresa I; Porcalla, Ariel; Gonzalez, Yuri Sanchez; Burroughs, Margaret; Sokal, Etienne
炎症/感染
肝炎
微生物学
发表日期：2020
文献求助 收藏

Safety and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1-6 Hepatitis C Virus Infections and Compensated Liver Disease

格卡瑞韦/哌仑他韦在患有慢性基因1-6型丙型肝炎病毒感染和代偿性肝病的成人中的安全性和药代动力学

期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciz022
Gane, Edward; Poordad, Fred; Zadeikis, Neddie; Valdes, Joaquin; Lin, Chih-Wei; Liu, Wei; Asatryan, Armen; Wang, Stanley; Stedman, Catherine; Greenbloom, Susan; Nguyen, Tuan; Elkhashab, Magdy; Wörns, Marcus-Alexander; Tran, Albert; Mulkay, Jean-Pierre; Setze, Carolyn; Yu, Yao; Pilot-Matias, Tami; Porcalla, Ariel; Mensa, Federico J
炎症/感染
肝炎
微生物学
发表日期：2019
文献求助 收藏

Efficacy and Safety of 8 Weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve, HCV-Infected Patients with APRI ≤ 1 in a Single-Arm, Open-Label, Multicenter Study

在一项单臂、开放标签、多中心研究中，评估格卡瑞韦/哌仑他韦治疗8周对APRI≤1的初治HCV感染患者的疗效和安全性

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-019-01123-0
Fontana, Robert J; Lens, Sabela; McPherson, Stuart; Elkhashab, Magdy; Ankoma-Sey, Victor; Bondin, Mark; Dos Santos, Ana Gabriela Pires; Xue, Zhenyi; Trinh, Roger; Porcalla, Ariel; Zeuzem, Stefan
炎症/感染
APR
发表日期：2019
文献求助 收藏

Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection

丙型肝炎病毒感染的肝肾移植患者接受格卡瑞韦/哌仑他韦治疗

期刊:Hepatology
影响因子:15.8
doi:10.1002/hep.30046
Reau, Nancy; Kwo, Paul Y; Rhee, Susan; Brown, Robert S Jr; Agarwal, Kosh; Angus, Peter; Gane, Edward; Kao, Jia-Horng; Mantry, Parvez S; Mutimer, David; Reddy, K Rajender; Tran, Tram T; Hu, Yiran B; Gulati, Abhishek; Krishnan, Preethi; Dumas, Emily O; Porcalla, Ariel; Shulman, Nancy S; Liu, Wei; Samanta, Suvajit; Trinh, Roger; Forns, Xavier
炎症/感染
肝炎
微生物学
发表日期：2018
文献求助 收藏